as of 3/13/2013
Trust |
Cumulative Total Return1 | Average Annual Total Return2 | ||||||
|---|---|---|---|---|---|---|---|---|
| Distributions Reinvested | 3 Month | 6 Month | YTD | Since Inception | 1 Year | 3 Year | 5 Year | Since Inception |
| With Transactional Sales Charge (18386F839) | 4.13% | 1.26% | 0.46% | 12.46% | 8.68% | 4.11% | 2.42% | 2.37% |
| Without Transactional Sales Charge (18386F854) | 8.59% | 5.64% | 4.80% | 17.70% | 13.41% | 5.65% | 3.36% | 3.31% |
| Distributions Received in Cash | ||||||||
| With Transactional Sales Charge (18386F821) | 4.11% | 1.07% | 0.44% | -0.40% | 5.49% | 2.26% | -0.03% | -0.08% |
| Without Transactional Sales Charge (18386F847) | 8.57% | 5.45% | 4.78% | 5.44% | 11.94% | 4.25% | 1.11% | 1.06% |
Benchmarkas of 3/13/2013 |
||||||||
| CBOE BuyWrite Monthly Index (BXM) | 3.93% | 0.53% | 2.76% | 16.02% | 4.82% | 6.50% | 2.92% | 3.01% |
between
Trust |
Cumulative Total Return1 | Average Annual Total Return2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Distributions Reinvested | ||||||||||||
| With Transactional Sales Charge (18386F839) | 12.46% | 2.37% | ||||||||||
| Without Transactional Sales Charge (18386F854) | 17.70% | 3.31% | ||||||||||
| Distributions Received in Cash | ||||||||||||
| With Transactional Sales Charge (18386F821) | -0.40% | -0.08% | ||||||||||
| Without Transactional Sales Charge (18386F847) | 5.44% | 1.06% | ||||||||||
Benchmark |
||||||||||||
| CBOE BuyWrite Monthly Index (BXM) | 16.02% | 3.01% | ||||||||||
Performanceas of 5/21/25 |
Cumulative Total Return1 (Since Inception*) |
Average Annual Total Return2 (Since Inception*) |
|||||||
| Trust | Deposit Date |
Maturity Date |
Distributions Reinvested Without Transactional Sales Charge |
Distributions Reinvested With Transactional Sales Charge |
CBOE BuyWrite Monthly Index (BXM) | Distributions Reinvested Without Transactional Sales Charge |
Distributions Reinvested With Transactional Sales Charge |
CBOE BuyWrite Monthly Index (BXM) | |
|---|---|---|---|---|---|---|---|---|---|
This data is for information purposes only. Past performance does not guarantee future results and performance of one series does not represent potential performance of any subsequent series. *Performance data is only available once a trust has been in the primary market for one month.
1 Cumulative total return measures the terminal value of an investment relative to the initial value of the investment and is expressed as a percentage gain (loss), and does not take into account the length of time over which the investment was held. The terminal value of an investment takes into account both capital appreciation (depreciation) and reinvestment of income and capital distributions into additional units of the trust, except for trusts that do not offer the option of reinvesting distributions into additional units. The terminal value also takes into account maximum allowable sales charges and all applicable expenses of the trust.
2 Average annual total return is the compounded annual return that if constantly earned over the same time period as the investment would have equated to the same terminal value as the investment, and is expressed as an annual percentage gain or loss. The terminal value of an investment takes into account both capital appreciation (depreciation) and reinvestment of income and capital distributions into additional units of the trust, except for trusts that do not offer the option of reinvesting distributions into additional units. The terminal value also takes into account maximum allowable sales charges and all applicable expenses of the trust.
Past performance does not guarantee future results. It is possible to lose money investing in this portfolio. Average annual total return calculations take into account reinvestment of all distributions and payment of the trust's maximum applicable up-front and deferred sales charge. Please refer to each trust's highlight card and prospectus for applicable sales charges and expenses. The value of units will fluctuate with changes in market conditions and units, when redeemed, may be worth more or less than their original cost.
Returns With Transactional Sales Charge reflect the maximum transactional sales charge that would be payable by an investor upon sale or redemption of units at the end of the applicable period(s). The transactional sales charge includes any initial or deferred sales charges other than the creation and development fee. These returns do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.
Returns Without Transactional Sales Charge do not reflect any transactional sales charge and do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.
Returns with distributions reinvested assumes distributions are reinvested on the reinvestment date. Product returns will be understated for the period between the distribution Ex-date and Payable-date, if a distribution is expected.
As of 9/6/2019 the comparative benchmark changed from the Morningstar All Taxable US CEF Peer Group Index to the Morningstar All US CEF Peer Group Index
CBOE BuyWrite Monthly Index (BXM): CBOE S&P BuyWrite Index (BMI) is a benchmark index maintained by the Chicago Board Options Exchange and designed to reflect the performance of a portfolio consisting of a long position in the stocks for the S& P 500 Index and a short position in an S&P 500 call option.
This information does not constitute an offer to sell or a solicitation of any offer to buy: nor shall there be any sale of these securities in any state where the offer, solicitation, or sale is not permitted.
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.